Novo Nordisk partners with Anthropic on drug discovery
Novo Nordisk will partner with Anthropic to speed up drug development efforts.
Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
7 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
Novo Nordisk will partner with Anthropic to speed up drug development efforts.
Novo Nordisk said it will partner with Anthropic to deploy AI models for drug discovery and develop next-generation medicines.
Novo says it will partner with Anthropic on drug-discovery challenges identified by Novo scientists, using AI-based tools for biological reasoning and scientific workflows.
Novo Nordisk said it has partnered with Anthropic to use Claude models to speed discovery and development of new medicines.
Novo Nordisk said it is teaming up with Anthropic to deploy the Claude AI model to accelerate development of new medicines.
more on NVO Novo Nordisk: Partners With Anthropic to Advance Drug Discovery and AI-Driven R&D ⠀ • Novo will use Anthropic's Claude models, including Claude Science, for biological reasoning, drug discovery workflows and software engineering. • Initial work will target specific R&D problems where Novo and Anth
Novo Nordisk and Anthropic formed a collaboration to use Claude Science and frontier models to apply AI to R&D workflows and AI-driven software development, aiming to accelerate discovery of new medicines.